Clinical Trial

Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa

Study acronym: ANO-TERV
Recruiting
View on ClinicalTrials.gov →
Summary
Anorexia nervosa is defined in DSM V as a quantitative and qualitative dietary restriction resulting in significant weight loss, intense fear of weight gain, altered weight and body shape perception (body dysmorphic disorder) and low self-esteem influenced by weight or body shape. Body dysmorphic disorder is the most difficult symptom to manage in anorexia nervosa and its persistence is a factor associated with relapse. Virtual reality exposure therapy has proven its effectiveness in the management of post-traumatic stress disorder in the military and is a widely used therapy. The effectiveness of this treatment using new technologies has not yet been studied for the treatment of body dysmorphic disorder in anorexia nervosa and is not used routinely. It could represent an interesting alternative to the physical approach in psychomotor therapy, traditionally offered to patients suffering from anorexia nervosa. It is important to evaluate the effectiveness of virtual reality exposure therapy in the management of body dysmorphic disorder in patients with anorexia nervosa by comparing these two care techniques.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-09-26; most recent amendment 2023-03-07.
Status change: Not Yet Recruiting → Recruiting 2021-06-25
Trial Details
NCT Number NCT04107870
Lead Sponsor CHU de Reims
Conditions Anorexia Nervosa
Enrollment 40 participants
Start Date 2021-06-20
Primary Completion 2027-03-20 (estimated)
Study Completion 2028-09-20 (estimated)
Updated on ClinicalTrials.gov 2023-03-08